comparemela.com

Latest Breaking News On - Gunnar olsson - Page 5 : comparemela.com

IRLAB publishes Annual Report for 2023

GOTHENBURG, SWEDEN / ACCESSWIRE / April 29, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA), a company discovering and developing novel treatments for Parkinson's disease, announced today that the Annual Report for 2023 is published on the company's website, www.irlab.se.IRLAB today has published the Annual Report.

Vastra gotalands lanViktor siewertzArvid carlssonGunnar olssonMichaelj fox foundationAnnual reportSecurities marketsNobel laureateIntegrative screening processNasdaq stockholm

IRLAB to Present at the Bayes@Lund 2024 Conference in Lund, Sweden on March 7

GOTHENBURG, SWEDEN / ACCESSWIRE / February 28, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, February 28, 2024 - IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a company discovering and developing novel treatments for Parkinson's disease, today announced that the company will present at th.

Vastra gotalands lanGunnar olssonErik wernerArvid carlssonMichaelj fox foundationNasdaq stockholmNobel laureateIntegrative screening process

IRLAB to Present at the Bayes@Lund 2024 Conference in Lund, Sweden

IRLAB to Present at the Bayes@Lund 2024 Conference in Lund, Sweden .

Vastra gotalands lanArvid carlssonErik wernerGunnar olssonNews networkMichaelj fox foundationNasdaq stockholmNobel laureateIntegrative screening process

IRLAB to Present Clinical and Preclinical Data at the AD/PD(TM) 2024: 18th International Conference on Alzheimer s & Parkinson s Diseases

27.02.2024 - GOTHENBURG, SWEDEN / ACCESSWIRE / February 27, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, February 27, 2024 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for .

Li rouskJenny gunnergrenJoakim tedroffAngelica johanssonDaniel anderssonGunnar olssonOlivia vu vanArvid carlssonSabina brandinDrug developmentResearch developmentMichaelj fox foundationPlacebo controlled phaseTrial evaluatingFalls frequencyClas sonesson

IRLAB to Present Clinical and Preclinical Data at the AD/PD(TM) 2024:

IRLAB to Present Clinical and Preclinical Data at the AD/PD(TM) 2024: .

Vastra gotalands lanGunnar olssonLi rouskSabina brandinJoakim tedroffArvid carlssonJenny gunnergrenOlivia vu vanAngelica johanssonDaniel anderssonMichaelj fox foundationInternational conference on alzheimerDrug developmentResearch developmentInternational conference on alzheimer parkinson diseasesNews network

vimarsana © 2020. All Rights Reserved.